Biotech News - Page 2
OMICS Group Scientific Innovations on VK.Com
March 22, 2013
OMICS Group in publishing scientific research articles and gathering delegates with high credentials for the scientific events at various venues across the globe.
March 22, 2013
OMICS Group in publishing scientific research articles and gathering delegates with high credentials for the scientific events at various venues across the globe.
Biotech Growth to Slow Down in the US
March 18, 2013
Recombinant proteins, which currently account for around 60% of the total US biopharmaceutical sales, are expected to be the worst hit during the forecast period.
March 18, 2013
Recombinant proteins, which currently account for around 60% of the total US biopharmaceutical sales, are expected to be the worst hit during the forecast period.
G. Steven Burrill to give featured presentation at Diabetes Summit 2013 (April 29-30 in Boston, MA)
March 12, 2013
G. Steven Burrill to present at Diabetes Summit 2013 (April 29-30 in Boston, MA)
March 12, 2013
G. Steven Burrill to present at Diabetes Summit 2013 (April 29-30 in Boston, MA)
New Industrial Biodegradable & Compostable Tensioning Film
March 5, 2013
Tawaho Management Limited, a sustainable market development company, in collaboration with USA based New Composite Partners, has recently announced the availability of a new exciting product as an alternative to conventional polyethylene films.
March 5, 2013
Tawaho Management Limited, a sustainable market development company, in collaboration with USA based New Composite Partners, has recently announced the availability of a new exciting product as an alternative to conventional polyethylene films.
OMICS Publishing Group scientific blog
February 28, 2013
The OMICS Publishing Group Scientific Blog highlights the contributions made by several authors in the respective field. The other activities of the OMICS Group like the links for Conferences are also placed on the page.
February 28, 2013
The OMICS Publishing Group Scientific Blog highlights the contributions made by several authors in the respective field. The other activities of the OMICS Group like the links for Conferences are also placed on the page.
OMICS Publishing Group MD
February 26, 2013
The world of science needs constant efforts for the support of ongoing research. This was realized and felt deeply by the OMICS Publishing Group MD, Dr Srinubabu Gedela.
February 26, 2013
The world of science needs constant efforts for the support of ongoing research. This was realized and felt deeply by the OMICS Publishing Group MD, Dr Srinubabu Gedela.
Synowledge to Exhibit at 25th Annual DIA EuroMeeting
February 25, 2013
Synowledge, LLC is pleased to announce that it will exhibit at the 25th Annual Drug Information Association (DIA) EuroMeeting in Amsterdam, Netherlands on March 4-6th, 2013.
February 25, 2013
Synowledge, LLC is pleased to announce that it will exhibit at the 25th Annual Drug Information Association (DIA) EuroMeeting in Amsterdam, Netherlands on March 4-6th, 2013.
Synowledge Launches Life Sciences and IT Webinar Series
February 25, 2013
Synowledge, LLC is pleased to announce the launch of its free Synowledge Webinar Series encompassing relevant industry topics in pharmacovigilance, regulatory affairs, and IT.
February 25, 2013
Synowledge, LLC is pleased to announce the launch of its free Synowledge Webinar Series encompassing relevant industry topics in pharmacovigilance, regulatory affairs, and IT.
Riccardo Perfetti to Speak at Diabetes Summit 2013 (April 29-30 in Boston, MA)
February 21, 2013
Diabetes Summit 2013 brings together venture capitalists, industry authoritative experts and leaders from academic institutions to cover many current and relevant aspects of Diabetes
February 21, 2013
Diabetes Summit 2013 brings together venture capitalists, industry authoritative experts and leaders from academic institutions to cover many current and relevant aspects of Diabetes
Growth in the Pharmaceutical Industry Shifting from the Developed to the Emerging Markets
February 14, 2013
Future growth in the developed pharmaceutical markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures.
February 14, 2013
Future growth in the developed pharmaceutical markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures.